<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In the present study, we evaluated the neuroprotection time window for nerve growth factor (NGF) after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion brain injury in rabbits as related to this anti-<z:mpath ids='MPATH_3'>apoptosis</z:mpath> mechanism </plain></SENT>
<SENT sid="1" pm="."><plain>Male New Zealand rabbits were subjected to 2 h of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO), followed by 70 h of reperfusion </plain></SENT>
<SENT sid="2" pm="."><plain>NGF was administered after injury to evaluate the time window </plain></SENT>
<SENT sid="3" pm="."><plain>Neurological deficits, <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, neural cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and expressions of caspase-3 and Bcl-2 were measured </plain></SENT>
<SENT sid="4" pm="."><plain>Compared to saline-treated control, NGF treatment at 2, 3 and 5 h after MCAO significantly reduced <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, neural cell <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and expression of caspase-3 (P &lt; 0.01), up-regulated the expression of Bcl-2 and improved functional recovery (P &lt; 0.01) </plain></SENT>
<SENT sid="5" pm="."><plain>However, treatment at latter time points did not produce significant neuroprotection </plain></SENT>
<SENT sid="6" pm="."><plain>Neuroprotection treatment with NGF provides an extended time window of up to 5 h after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/reperfusion brain injury, in part by attenuating the <z:mpath ids='MPATH_3'>apoptosis</z:mpath> </plain></SENT>
</text></document>